Stock listing
Jupiter Neurosciences, Inc.
Selected listing: JUNS · NASDAQ · USD · US
Jupiter Neurosciences, Inc. (NASDAQ:JUNS), Health Technology. Latest release Aug 5, 2026: Jupiter Neurosciences, Inc. Announces Reverse Stock Split.
- Ticker
- NASDAQ:JUNS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Jupiter Neurosciences, Inc.
The company focuses on developing innovative solutions in the field of neuroscience. Investors can track its performance and updates on the stock market.
Latest news from Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Announces Reverse Stock Split
August 5, 2026
Jupiter Neurosciences Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
July 22, 2026
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
July 21, 2026
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
July 6, 2026
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
May 26, 2026
Research Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. company profile
View the public company page for Jupiter Neurosciences, Inc. on 6ix.
Jupiter Neurosciences, Inc. news
Read company news and market updates connected to Jupiter Neurosciences, Inc..
Jupiter Neurosciences, Inc. investor events
Find investor webinars, events, and replay context for Jupiter Neurosciences, Inc..